As LUNGevity seeks to empower patients to be active decision-makers in their treatment
process through our extensive educational resources, online peer-to-peer support, and
in-person survivorship programs, we also want our entire community to be able to make other
critical choices that impact your future. August is National Make-A-Will Month, and it’s the
The landscape of lung cancer is changing for the better. Due to progress in research and drug development, there are more treatment options and hope for the lung cancer community than ever before.
Sherry Jones and her family are carrying on the torch for Living Wide, an inspirational movement started by Gregory Jones after his lung cancer diagnosis in 2016. According to Living Wide’s website, Gregory dedicated himself to maximizing the width of his life because he had no control over the length.
While targeted therapies have emerged in the past decade to improve treatment of non-small cell lung cancer (NSCLC) with some types of driver mutations (such as EGFR and ALK), lung adenocarcinomas with KRAS driver mutations have been notoriously difficult to study and treat.
On June 1st, 2022, LUNGevity Foundation hosted a Facebook Live to discuss our manuscript titled “The 2021 Global Lung Cancer Therapy Landscape” published in the Journal of Thoracic Oncology.
The conference presents the latest science behind living well with lung cancer through educational sessions, expert panels, and special breakout groups
